These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 12381273)
1. [Post-transplantation vaccination of bone-marrow transplant recipients]. Adell C; Bayas JM; Vilella A; Perales M; Vidal J; Bertran MJ; Rojano X; Asenjo MA Med Clin (Barc); 2002 Oct; 119(11):405-9. PubMed ID: 12381273 [TBL] [Abstract][Full Text] [Related]
2. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078 [TBL] [Abstract][Full Text] [Related]
3. A national survey of immunization practices following allogeneic bone marrow transplantation. Henning KJ; White MH; Sepkowitz KA; Armstrong D JAMA; 1997 Apr; 277(14):1148-51. PubMed ID: 9087470 [TBL] [Abstract][Full Text] [Related]
5. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines. Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412 [TBL] [Abstract][Full Text] [Related]
6. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
7. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123 [TBL] [Abstract][Full Text] [Related]
8. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Laws HJ; Calaminus G; Göbel U Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299 [No Abstract] [Full Text] [Related]
9. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Fioredda F; Giacchino M; Castagnola E Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298 [No Abstract] [Full Text] [Related]
11. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129 [TBL] [Abstract][Full Text] [Related]
12. Vaccinations, response, and controls before and after intestinal transplantation in children. Demir Z; Frange P; Lacaille F Pediatr Transplant; 2016 May; 20(3):449-55. PubMed ID: 26847771 [TBL] [Abstract][Full Text] [Related]
13. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports. Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821 [TBL] [Abstract][Full Text] [Related]
14. Adolescent immunizations: missed opportunities for prevention. Lee GM; Lorick SA; Pfoh E; Kleinman K; Fishbein D Pediatrics; 2008 Oct; 122(4):711-7. PubMed ID: 18829792 [TBL] [Abstract][Full Text] [Related]
15. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018. Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961 [TBL] [Abstract][Full Text] [Related]
17. Successful restoration of protective immunity against measles, mumps, and rubella following MMR vaccination in adult hematopoietic cell transplant recipients. Lin RY; Anderson AD; Morris MI; Raja M; Komanduri KV; Camargo JF Transpl Infect Dis; 2023 Apr; 25(2):e14043. PubMed ID: 36880572 [TBL] [Abstract][Full Text] [Related]
18. Low immunity against vaccine preventable diseases in Turkish HIV cohort. Candevir A; Kuşcu F; Yıldırım F; Kömür S; Şentürk GÇ; İnal AS; Eser F; Çetiner S; Kurtaran B; Taşova Y Turk J Med Sci; 2021 Oct; 51(5):2311-2317. PubMed ID: 33984893 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds. Cassidy WM; Jones G; Williams K; Deforest A; Forghani B; Virella G; Venters C J Adolesc Health; 2005 Mar; 36(3):187-92. PubMed ID: 15737773 [TBL] [Abstract][Full Text] [Related]